When patients undergo surgery or procedures to open blocked arteries in their legs, doctors look for ways to predict who might face the toughest road ahead. New data suggests that the size of a specific deep muscle called the psoas major could be a key indicator of a patient's long-term health.
Researchers looked at 2,290 adults with peripheral arterial disease (PAD). They found that patients with a smaller psoas muscle area had a significantly higher risk of death one year after their procedure. While the data for deaths within the first month was less certain and not statistically significant, the link to long-term mortality was clear.
This finding suggests that measuring muscle size could help doctors identify high-risk patients sooner. However, because the analysis relied on a small number of studies, more research is needed to confirm these patterns. This is an observation of risk, not a test of a new treatment.
Common questions
What is the psoas muscle and why does it matter?
The psoas major is a deep muscle in the lower back and hip area. In this study, researchers found that the size of this muscle could serve as a marker to predict survival for patients with peripheral arterial disease (PAD) after they undergo surgery or other procedures to open their arteries.
How does muscle size affect outcomes for PAD patients?
The study found that a smaller psoas major muscle area was linked to an increased risk of death one year after treatment. While the link to mortality within the first month was not statistically significant, the long-term data showed a clear association between smaller muscle size and higher mortality.
Is this finding used to change how patients are treated?
This study shows an association between muscle size and survival risk, but it was not a trial of a new treatment. Because the analysis included a small number of studies, these results should be discussed with a doctor to understand what they mean for specific patient care.
